Published in
Elsevier, Clinical Lung Cancer, 4(23), p. 333-344, 2022
DOI: 10.1016/j.cllc.2022.02.001
Links
Tools
Controversies in Lung Cancer: Heterogeneity in Treatment Recommendations for Stage III NSCLC According to Disease Burden and Oncogenic Driver Alterations
Journal article published in 2022 by
Jeremy P. Harris,
Dylann K. Fujimoto,
Misako Nagasaka 
,
Eric Ku,
Garrett Harada ,
Hari Keshava,
Ali Mahtabifard,
Javier Longoria,
Niral Patel ,
Steven Seyedin,
Aaron Simon ,
Allen Chen
,
Eric Ku,
Garrett Harada ,
Hari Keshava,
Ali Mahtabifard,
Javier Longoria,
Niral Patel ,
Steven Seyedin,
Aaron Simon ,
Allen Chen
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 